Biohaven (BHVN) Other Non Operating Income (2021 - 2024)
Biohaven (BHVN) reported Other Non Operating Income of $4.3 million for Q1 2024, down 47.69% on a YoY basis from $8.2 million in Q2 2023, and down 44.4% sequentially from $7.7 million in Q4 2023.
Biohaven (BHVN) Other Non Operating Income (2021 - 2024) Analysis & Trends
Biohaven (BHVN) has 4 years of Other Non Operating Income data on file, last reported at $4.3 million in Q1 2024.
- For the quarter ending Q1 2024, Other Non Operating Income fell 47.69% year-over-year to $4.3 million; the trailing twelve-month figure through Mar 2024 stood at $22.6 million (up 256.99% YoY), and the FY2025 full-year result was $8.0 million, down 79.71% from the prior year.
- Other Non Operating Income slipped to $4.3 million in Q1 2024, from $7.7 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $8.2 million in Q1 2023 to a low of -$1.8 million in Q4 2022.
- A 4-year average of $3.0 million and a median of $2.9 million in 2021 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income tumbled 226.41% in 2022 and soared 205825.0% in 2023, its largest moves.
- Tracing BHVN's Other Non Operating Income over 4 years: stood at $1.5 million in 2021, then plunged by 226.41% to -$1.8 million in 2022, then surged by 521.27% to $7.7 million in 2023, then slumped by 44.4% to $4.3 million in 2024.
- Business Quant data shows BHVN's Other Non Operating Income at $4.3 million in Q1 2024, $7.7 million in Q4 2023, and $4.7 million in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Biohaven | 2.13 Bn | 1.78 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 4.31 Mn |
| Dec 31, 2023 | 7.74 Mn |
| Sep 30, 2023 | 4.69 Mn |
| Jun 30, 2023 | 5.84 Mn |
| Mar 31, 2023 | 8.23 Mn |
| Dec 31, 2022 | -1.84 Mn |
| Jun 30, 2022 | -67,000.00 |
| Mar 31, 2022 | -4,000.00 |
| Dec 31, 2021 | 1.45 Mn |
| Sep 30, 2021 | -5,000.00 |